Masaki Katayama

9PUBLICATIONS
48CO-AUTHORS
Metabolic medicineRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2025
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort Study.

Kosuke Ebina, Yuki Etani, Yasutaka Okita

|Aug 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.

Kosuke Ebina, Yuki Etani, Yuichi Maeda

|Mar 10, 2022
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.

Yoichi Nakayama, Ryu Watanabe, Kosaku Murakami

|Apr 27, 2021
Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.

Yuichi Maeda, Toru Hirano, Kosuke Ebina

|Jan 30, 2021
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study.

Kosuke Ebina, Toru Hirano, Yuichi Maeda

|Jul 31, 2020
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study.

Sadao Jinno, Akira Onishi, Maureen Dubreuil

Pageof 2

Frequent Collaborators

8 joint publications

Ryota Hara

8 joint publications

Kosuke Ebina

8 joint publications

Motomu Hashimoto

8 joint publications

Wataru Yamamoto